Article info

Download PDFPDF

Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis
  1. Correspondence to:
 Professor Oluf Andersen
 Institute of Clinical Neuroscience, Neurologen-Sahlgrenska, Sahlgrenska University Hospital, SE 413 45 Göteborg, Sweden; oluf.andersenneuro.gu.se
View Full Text

Citation

Andersen O, Elovaara I, Färkkilä M, et al
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis

Publication history

  • Received January 12, 2003
  • Accepted August 6, 2003
  • Revised July 28, 2003
  • First published April 16, 2004.
Online issue publication 
April 16, 2004

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.